Drug Pipelines for Multiple Sclerosis Examined in Depth Inside New Report
Posted on: Thursday, 13 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68284) has announced the addition of "Central Nervous System - Multiple Sclerosis Drug Pipeline Report" to their offering.
"Central Nervous System - Multiple Sclerosis Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of multiple sclerosis drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Contents:
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Multiple Sclerosis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Multiple Sclerosis Projects
--Top 20 companies in early stage Multiple Sclerosis Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68284.
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Pima County, Arizona Contracts with Motorola to Provide Project 25 Phase 2 TDMA
- Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
- Heartland Oil and Gas Continues Production Enhancement and Well and Pipeline Expansion Projects in Texas and Kansas
- BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
- Central Nervous System Stroke Drug Pipeline Report Provides the User With Real Details on Stroke Drug Pipelines By Company and By Stage
- View Details on the Top 20 Companies With Products in the Early Stage of Development for Non-Small-Cell Lung Cancer, Lung Cancer or Small Cell Lung Cancer
- BP Launches Open Season on Proposed Pipeline Reversal Project to Bring Light Canadian Crude to Cushing
- Energy Transfer Partners, L.P. Continues Timely Completion of 42-Inch Pipeline Construction Project
- Energy Transfer Partners, L.P. Announces Completion of First Phase of 42-Inch Pipeline Expansion Project
- Green Hills Software and I-Logix Redefine ``Integrated Development Environment'' With First Single Source Solution Addressing All Phases of Embedded Systems Development
 |
 |
User Comments (0)
RSS Feeds